Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 1 Study of JMKX003142 in Healthy Adults
NCT06079541Phase 1Unknown
- Sponsor
- Jemincare
- Start
- Jul 2023
- Primary completion
- Jul 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of JMKX003142 in autosomal dominant polycystic kidney disease (ADPKD) and renal edema (5 arms), sponsored by Jemincare. Primary endpoints: Number of Adverse Events related to single dose treatment and Number of Adverse Events related to multiple dose treatment. Status: unknown.
02
Drugs
JMKX003142
03
Conditions
autosomal dominant polycystic kidney disease (ADPKD)renal edema
Beyond the preview
Go deeper on NCT06079541.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06079541.